Real-World Data: ‘Don’t Take Your Foot Off The Gas’
Executive Summary
It is possible to maintain the current focus on the use of real-world data in drug development by finding simple solutions to existing challenges, argues an expert at a US-based RWD platform.
You may also be interested in...
How COVID-19 Is Driving RWE Uptake In Clinical Trials
With the COVID-19 pandemic exacerbating the challenges of recruiting patients for studies targeting catastrophic diseases and rare cancers, regulators are becoming more receptive to new ways of using real-world evidence in clinical trials.
New Big Data Curriculum On The Cards For EU Regulators
The European Medicines Agency is inviting feedback from organizations interested in delivering a training program to the members of the European medicines regulatory network to improve their big data analysis and assessment skills.
New UK System Will Check Trial Sponsors Report Study Results
The UK has started monitoring whether clinical trial sponsors are fulfilling responsibilities to make their research open and transparent.